WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, will sponsor a breakfast ...

Shares of Corindus Vascular Robotics (NYSEMKT: CVRS) , a robotic surgery company focused on vascular disease, fell 22% as of 3:39 p.m. EDT on Thursday after fourth-quarter results were released.

WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, today announced that Martin Leon, MD, one of the preeminent ...

NATICK, Mass., Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced leading experts in interventional cardiology will speak about their clinical experience ...

Corindus Vascular Robotics, Inc. CVRS was a big mover last session, as its shares rose over 19% on the day. The move came on solid volume too with far more shares changing hands than in a normal ...

WALTHAM, Mass.--(BUSINESS WIRE)-- At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the adoption of the ...

PRECISION Registry will collect data from sites nationwide to study use of CorPath in routine clinical practice WALTHAM, Mass.--Corindus Vascular Robotics, a leading developer of precision vascular ...

Corindus Vascular Robotics, Inc. (NYSEMKT: CVRS), a company developing robotic-assisted vascular intervention devices, is on the move just ahead of its fourth-quarter earnings report expected after ...

Shares of Corindus Vascular Robotics Inc. rocketed 76% toward a 4-year high in very active premarket trading Thursday, after the robotic-assisted vascular interventions company agreed to be acquired ...

Securities and Exchange Commission filings have revealed that Louis Cannon, who is listed as a director at Corindus, substantially added to his position in the company's stock this week. Cannon ...